// App-Quantinova.ai

1998 : An analysis of the NeoALTTO clinical trial

Researchers

Presenter

  • Mattia Rediti

Principal Investigators

  • Franoise Roth

  • Tao Qing

  • Marion Maetens

  • Ian Bradbury

  • Miguel A. Izquierdo

  • Serena Di Cosimo

  • Florentine Hilbers

  • Mohammed Bajji

  • Nadia Harbeck

  • Michael Untch

  • David L. Rimm

  • Stephen Chia

  • Minetta C. Liu

  • Cristina Saura

  • Jens Huober

  • Paolo Nuciforo

  • Roberto Salgado

  • Sherene Loi

  • Lajos Pusztai

  • Christos Sotiriou

Medical Centers

  • Institute Jules Bordet, Brussels, Belgium

  • Yale Cancer Center, New Haven, CT

  • KU Leuven, Leuven, Belgium

  • Frontier Science Scotland, Kingussie, United Kingdom

  • Novartis AG, Basel, Switzerland

  • SOLTI Breast Cancer Research Group, Barcelona, Spain

  • Breast International Group, Brussels, Belgium

  • Ludwig Maximilians University Munich, Munich, Germany

  • HELIOS Klinikum Berlin-Buch, Berlin, Germany

  • Yale University School of Medicine, New Haven, CT

  • BC Cancer Agency, Vancouver, British Columbia, Canada.

  • Mayo Clinic, Rochester, MN

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • University of Ulm, Ulm, Germany

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

Locations

  • Belgium

  • United States

  • United Kingdom

  • Switzerland

  • Spain

  • Germany

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved